Topical Treatment Habits in Psoriasis Patients Receiving Adalimumab
Dermatology, 07/05/2012
Clinical Article
Kolios AGA et al. – Topical treatment use by adalimumab patients is associated with remaining disease activity. 83% of patients without residual plaques (40% of all adalimumab patients) are able to stop topical treatment completely.



